查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1527275

全球藥品合約包裝市場規模研究，依產品類型、形式類型、應用類型和區域預測 2022-2032

Global Pharmaceutical Contract Packaging Market Size Study, by Product Type, by Form Type, by Application Type and Regional Forecasts 2022-2032
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 285 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年全球藥品合約包裝市場價值約為61億美元，預計在2024-2032年預測期內將以超過7.5%的健康成長率成長。藥品合約包裝是將藥品的包裝流程外包給專業的第三方公司，由其提供泡殼包裝、裝瓶、貼標和二次包裝等服務。這使得製藥公司能夠專注於藥物開發和行銷等核心活動，同時確保遵守監管標準。合約包裝商提供包裝技術、品質控制和供應鏈管理的專業知識，有助於降低成本、提高效率並確保整個分銷過程中的產品安全和完整性。

日益嚴格的品質要求以及將藥品包裝外包給新興國家的合約包裝商預計將在預測期內推動市場發展。製藥公司正在將包裝活動外包給合約包裝商，以降低整體生產成本並加快上市速度。預計這將有助於預測期內市場的成長。此外，缺乏內部包裝能力、專業知識和預算限制是該行業小型製藥公司面臨的主要問題。由於提供低成本服務，合約包裝服務提供者被認為是遏制小型公司此類問題的有效方法。然而，資源和預算的缺乏促使許多小型製藥公司與合約包裝組織（CPO）和合約開發和製造組織（CDMO）建立互惠互利的關係。合約服務提供者正在做出重大嘗試，以滿足客戶的期望並提供高度複雜的包裝設施。此外，全球不斷成長的製藥業預計將推動市場發展。由於包裝活動外包提供了多種好處，例如獲得先進的包裝技術、提高效率、專注於核心領域、獲得熟練的資源以及更快更好的服務，因此製藥公司擴大將包裝服務外包給CPO 和CDMO。

美國藥品供應鏈安全法案（DSCSA）和歐盟偽造藥品衍生性商品法案（FMD）等序列化的實施，強制要求在藥品包裝上使用條碼，並在藥品供應過程中傳輸大量資料。這使得製造公司開發適當的基礎設施來遵守這項新立法。序列化的引入預計將在預測期內推動市場發展。技術創新、人口成長、健康意識、先進製造技術的實施、公共衛生系統支出的增加以及政府實施控制傳染病傳播的新法規都是推動成長的因素。此外，對生物產品以及基因和細胞療法等新療法的需求不斷成長，有助於促進製藥公司的發展，從而增加對此類包裝產品的需求。

北美透過合約產生了全球對有效藥品包裝解決方案近三分之一的需求，佔據了領先的市場佔有率。根據計算，光是美國地區產生的總收入就佔北美總業務的 90% 左右。總部位於美國的 CPO 和 CDMO 提供的優質服務推動了該國對藥品合約包裝服務和解決方案的需求。對生物療法的需求、嚴格方案的增加以及老年人口的增加也可能擴大全球藥品合約包裝市場規模。然而，由於該地區存在大量合約包裝服務提供商，預計亞太地區在預測期內將出現最快的成長。這些參與者正致力於擴大其設施，以滿足製藥公司不斷成長的需求。此外，增加藥品製造外包給印度等新興國家正在進一步推動該地區市場的成長。

目錄

第 1 章：全球藥品合約包裝市場執行摘要

  • 全球藥品合約包裝市場規模及預測（2022-2032）
  • 區域概要
  • 分部摘要
    • 依產品類型
    • 依表格類型
    • 按應用程式類型
  • 主要趨勢
  • 經濟衰退的影響
  • 分析師推薦與結論

第 2 章：全球藥品合約包裝市場定義與研究假設

  • 研究目的
  • 市場定義
  • 研究假設
    • 包容與排除
    • 限制
    • 供給側分析
      • 可用性
      • 基礎設施
      • 監管環境
      • 市場競爭
      • 經濟可行性（消費者的角度）
    • 需求面分析
      • 監理框架
      • 技術進步
      • 環境考慮
      • 消費者意識和接受度
  • 估算方法
  • 研究涵蓋的年份
  • 貨幣兌換率

第 3 章：全球藥品合約包裝市場動態

  • 市場促進因素
    • 日益嚴格的品質要求
    • 不斷發展的製藥業
    • 對學名藥的需求
  • 市場挑戰
    • 缺乏內部包裝能力
    • 小型製藥公司的預算限制
  • 市場機會
    • 包裝技術創新
    • 對生物產品和新療法的需求不斷成長

第 4 章：全球藥品合約包裝市場產業分析

  • 波特的五力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭競爭
    • 波特五力模型的未來方法
    • 波特的五力影響分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會的
    • 技術性
    • 環境的
    • 合法的
  • 頂級投資機會
  • 最佳制勝策略
  • 顛覆性趨勢
  • 產業專家視角
  • 分析師推薦與結論

第 5 章：全球藥品合約包裝市場規模與預測：依產品類型 - 2022-2032

  • 細分儀表板
  • 全球藥品合約包裝市場：2022 年和 2032 年產品類型收入趨勢分析
    • 軟包裝
    • 塑膠或玻璃容器
    • 蓋子或封口

第 6 章：全球藥品合約包裝市場規模與預測：按形式類型 - 2022-2032

  • 細分儀表板
  • 全球藥品合約包裝市場：2022 年和 2032 年形式類型收入趨勢分析
    • 口服
    • 可注射

第 7 章：全球藥品合約包裝市場規模與預測：按應用類型 - 2022-2032

  • 細分儀表板
  • 全球藥品合約包裝市場：2022 年和 2032 年應用類型收入趨勢分析
    • 自體酸及相關藥物
    • 避孕藥具
    • 荷爾蒙替代品
    • 心血管藥物
    • 癌症治療

第 8 章：全球藥品合約包裝市場規模及預測：按地區 - 2022-2032

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 中東和非洲其他地區

第 9 章：競爭情報

  • 重點企業SWOT分析
  • 頂級市場策略
  • 公司簡介
    • Catalent Pharma Solutions
      • 關鍵訊息
      • 概述
      • 財務（視數據可用性而定）
      • 產品概要
      • 市場策略
    • Patheon
    • Baxter BioPharma Solutions
    • AbbVie Contract Manufacturing
    • Pfizer Centre Source
    • Daito Pharmaceutical
    • Nipro Corporation
    • Becton Dickinson & Company
    • AptarGroup Inc.
    • Drug Plastics Group

第 10 章：研究過程

  • 研究過程
    • 資料探勘
    • 分析
    • 市場預測
    • 驗證
    • 出版
  • 研究屬性
簡介目錄

The Global Pharmaceutical Contract Packaging Market is valued approximately at USD 6.1 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.5% over the forecast period 2024-2032. Pharmaceutical contract packaging involves outsourcing the packaging process of pharmaceutical products to specialized third-party companies, which provide services such as blister packing, bottling, labelling, and secondary packaging. This allows pharmaceutical companies to focus on core activities like drug development and marketing while ensuring compliance with regulatory standards. Contract packagers offer expertise in packaging technology, quality control, and supply chain management, helping to reduce costs, enhance efficiency, and ensure product safety and integrity throughout the distribution process.

Increasing stringent quality requirements and outsourcing of pharmaceutical packaging to contract packagers in emerging countries are expected to drive the market over the forecast period. Pharmaceutical companies are outsourcing the packaging activities to contract packagers to reduce the overall cost of production and speed to market. This is anticipated to contribute to the growth of the market over the forecast period. In addition, lack of in-house packaging capabilities, expertise, and budget constraints are the major issues faced by small pharmaceutical companies in the industry. Contract packaging service providers are recognized as an effective approach to curb such issues of the small companies owing to the low-cost service offering. However, lack of resources and budgets has prompted many small pharmaceutical companies to establish mutually beneficial relationships with Contract Packaging Organizations (CPOs) and Contract Development and Manufacturing Organizations (CDMOs). Contract service providers are making significant attempts to meet their client's expectations and provide highly sophisticated packaging facilities. Moreover, the growing pharmaceutical industry across the globe is anticipated to drive the market. As outsourcing of packaging activities offers several benefits such as access to advanced packaging technologies, increased efficiency, focus on core areas, access to skilled resources, and faster and better services, pharmaceutical companies are increasingly outsourcing the wrapping services to the CPOs and CDMOs.

The implementation of serialization including the Drug Supply Chain Security Act (DSCSA) in the U.S. and the EU Falsified Medicines Derivative (FMD) has mandated the barcodes on pharmaceutical packaging and the transfer of large volumes of data in the supply of medicines. This has made manufacturing companies develop appropriate infrastructure to comply with this new legislation. The introduction of serialization is expected to drive the market over the forecast period. Technological innovations, population increase, health awareness, the implementation of advanced manufacturing techniques, higher spending in public health systems, and the government implementation of new regulations to control the transmission of contagious diseases are all contributing factors to the growth. Furthermore, the growing demand for bio-products and new treatments such as gene and cell therapies are helpful to promote the pharmaceutical companies thereby increasing the demand for such packaging products.

North America accounts for the leading market share by generating almost one-third of the global demand for effective pharmaceutical packaging solutions through contracts. The total revenue generated by the United States alone was figured out to be around 90% of the total business in North America. Quality services offered by the CPOs and CDMOs based in the United States propel the demand for pharmaceutical contract packaging services and solutions in the country. The demand for biological therapies, increase in strict protocols, and rise in the geriatric population could also broaden the global pharma contract packaging market size. However, Asia Pacific is expected to witness the fastest growth over the forecast period due to the presence of a large number of contract packaging service providers in the region. These players are focusing on expanding their facilities to satisfy the growing needs of pharmaceuticals companies. In addition, increasing the outsourcing of pharmaceutical manufacturing to emerging countries such as India is further driving the growth of the market in the region.

Major market players included in this report are:

  • Catalent Pharma Solutions
  • Patheon
  • Baxter BioPharma Solutions
  • AbbVie Contract Manufacturing
  • Pfizer Centre Source
  • Daito Pharmaceutical
  • Nipro Corporation
  • Becton Dickinson & Company
  • AptarGroup Inc.
  • Drug Plastics Group
  • Gerresheimer AG
  • Schott AG
  • Owens Illinois Inc.
  • WestRock Company SGD S.A.
  • International Paper Company

The detailed segments and sub-segment of the market are explained below:

By Product Type:

  • Flexible Packaging
  • Plastic or Glass Containers
  • Caps or Closures

By Form Type:

  • Oral
  • Injectable

By Application Type:

  • Autacoids & Related Drugs
  • Contraceptives
  • Hormone Replacement
  • Cardiovascular Medicines
  • Cancer Therapies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Pharmaceutical Contract Packaging Market Executive Summary

  • 1.1. Global Pharmaceutical Contract Packaging Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Product Type
    • 1.3.2. By Form Type
    • 1.3.3. By Application Type
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Pharmaceutical Contract Packaging Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Pharmaceutical Contract Packaging Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Increasing Stringent Quality Requirements
    • 3.1.2. Growing Pharmaceutical Industry
    • 3.1.3. Demand for Generic Pharmaceuticals
  • 3.2. Market Challenges
    • 3.2.1. Lack of In-house Packaging Capabilities
    • 3.2.2. Budget Constraints for Small Pharmaceutical Companies
  • 3.3. Market Opportunities
    • 3.3.1. Technological Innovations in Packaging
    • 3.3.2. Rising Demand for Bio-products and New Treatments

Chapter 4. Global Pharmaceutical Contract Packaging Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Pharmaceutical Contract Packaging Market Size & Forecasts by Product Type 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Pharmaceutical Contract Packaging Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 5.2.1. Flexible Packaging
    • 5.2.2. Plastic or Glass Containers
    • 5.2.3. Caps or Closures

Chapter 6. Global Pharmaceutical Contract Packaging Market Size & Forecasts by Form Type 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Pharmaceutical Contract Packaging Market: Form Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 6.2.1. Oral
    • 6.2.2. Injectable

Chapter 7. Global Pharmaceutical Contract Packaging Market Size & Forecasts by Application Type 2022-2032

  • 7.1. Segment Dashboard
  • 7.2. Global Pharmaceutical Contract Packaging Market: Application Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 7.2.1. Autacoids & Related Drugs
    • 7.2.2. Contraceptives
    • 7.2.3. Hormone Replacement
    • 7.2.4. Cardiovascular Medicines
    • 7.2.5. Cancer Therapies

Chapter 8. Global Pharmaceutical Contract Packaging Market Size & Forecasts by Region 2022-2032

  • 8.1. North America Pharmaceutical Contract Packaging Market
    • 8.1.1. U.S. Pharmaceutical Contract Packaging Market
      • 8.1.1.1. Product Type breakdown size & forecasts, 2022-2032
      • 8.1.1.2. Form Type breakdown size & forecasts, 2022-2032
      • 8.1.1.3. Application Type breakdown size & forecasts, 2022-2032
    • 8.1.2. Canada Pharmaceutical Contract Packaging Market
  • 8.2. Europe Pharmaceutical Contract Packaging Market
    • 8.2.1. UK Pharmaceutical Contract Packaging Market
    • 8.2.2. Germany Pharmaceutical Contract Packaging Market
    • 8.2.3. France Pharmaceutical Contract Packaging Market
    • 8.2.4. Spain Pharmaceutical Contract Packaging Market
    • 8.2.5. Italy Pharmaceutical Contract Packaging Market
    • 8.2.6. Rest of Europe Pharmaceutical Contract Packaging Market
  • 8.3. Asia Pacific Pharmaceutical Contract Packaging Market
    • 8.3.1. China Pharmaceutical Contract Packaging Market
    • 8.3.2. India Pharmaceutical Contract Packaging Market
    • 8.3.3. Japan Pharmaceutical Contract Packaging Market
    • 8.3.4. Australia Pharmaceutical Contract Packaging Market
    • 8.3.5. South Korea Pharmaceutical Contract Packaging Market
    • 8.3.6. Rest of Asia Pacific Pharmaceutical Contract Packaging Market
  • 8.4. Latin America Pharmaceutical Contract Packaging Market
    • 8.4.1. Brazil Pharmaceutical Contract Packaging Market
    • 8.4.2. Mexico Pharmaceutical Contract Packaging Market
    • 8.4.3. Rest of Latin America Pharmaceutical Contract Packaging Market
  • 8.5. Middle East & Africa Pharmaceutical Contract Packaging Market
    • 8.5.1. Saudi Arabia Pharmaceutical Contract Packaging Market
    • 8.5.2. South Africa Pharmaceutical Contract Packaging Market
    • 8.5.3. Rest of Middle East & Africa Pharmaceutical Contract Packaging Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Catalent Pharma Solutions
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Market Strategies
    • 9.3.2. Patheon
    • 9.3.3. Baxter BioPharma Solutions
    • 9.3.4. AbbVie Contract Manufacturing
    • 9.3.5. Pfizer Centre Source
    • 9.3.6. Daito Pharmaceutical
    • 9.3.7. Nipro Corporation
    • 9.3.8. Becton Dickinson & Company
    • 9.3.9. AptarGroup Inc.
    • 9.3.10. Drug Plastics Group

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes